Internal Server Error

About Hamilton Apex

Hamilton Apex is a venture capital firm located in Solana Beach, United States. As of Aug 2004, Hamilton Apex has invested in 3 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Infrastructure. Most recently it participated in the $***** Series C round of Ceregene Overall, Hamilton Apex portfolio has seen 3 acquisitions, namely Santarus, Ceregene and Troika Networks. A lot of funds co-invest with Hamilton Apex, with names like SR One sharing a substantial percentage of its portfolio. Hamilton Apex has team of 1 people including 1 partners.
Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series C & 1 more
Portfolio Acquisitions

Hamilton Apex's List of All Investments

Hamilton Apex has a portfolio of 3 companies. Their most notable investments include Santarus and Ceregene.Their portfolio spans across and United States. They have invested in Life Sciences, High Tech, Enterprise Infrastructure and 1 other sectors, across stages such as Series A, Series C  and 1 more. Here is the list of all investments by Hamilton Apex:
Santarus, a specialty biopharmaceutical company is focused on acquiring, developing and commercializing proprietary products with a focus on gastrointestinal diseases. Its products include Uceris, approved last year for treating ulcerative colitis, as well as the stomach acid-reducing combination pill Zegerid. But Santarus also have products that work on conditions outside the gastrointestinal tract. It has two oral treatments for Type 2 diabetes, Glumetza and Cycloset, and Fenoglide, used to lower high cholesterol.

Key facts about Santarus

Develops AAV-based therapies for neurodegenerative and eye disorders. The company's lead candidate CERE-120 contains the gene for NTN which is delivered to the area of the brain degenerating in Parkinson’s disease, CERE-110 carries the gene for NGF used for Alzheimer’s disease, and CERE-130 is an Insulin-like growth factor used for amyotrophic lateral sclerosis.

Key facts about Ceregene

Troika Networks is a provider of Network Storage platform. Its platform known as Accelera optimizes storage applications and provides flexibility in adding capabilities to the network through a policy based design. This claims to help enterprises to leverage better data management and protection solutions.

Key facts about Troika Networks

Hamilton Apex's Investments by Stage

Hamilton Apex has made 1 investment in Series A stage with an average round size of $13M, 1 investment in Series C stage with an average round size of $32M and 1 investment in Series D stage with an average round size of $51.4M.
Here are Hamilton Apex's investments by stage:
Stage of entry
No. of Investments
Series A
1
Series C
1
Series D
1
Breakdown of Hamilton Apex's investments by stage of entrySeries A (1)Series C (1)
Note: We have considered here, only first round of investments

Hamilton Apex's Investments by Sector

Hamilton Apex has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, Enterprise Infrastructure and High Tech. Notably, it has invested in 2 Enterprise (B2B) companies, 2 Tech companies and 1 Software company.
Here are Hamilton Apex's investments by sector:
Sector
No. of Investments
Life Sciences
2
Enterprise Applications
1
Enterprise Infrastructure
1
High Tech
1
Breakdown of Hamilton Apex's investments by sectorsLife Sciences (2)Enterprise Applic... (1)
Note: We have considered here, only first round of investments

Hamilton Apex's Investments by Geography

Hamilton Apex has made most investments in United States (3).

Hamilton Apex's recent investments

Hamilton Apex has not made any investment in 2026 so far.
Here are the most recent investments by Hamilton Apex:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Aug 05, 2004
United States
Series C
5154
May 29, 2003
United States
Series A
9685
May 22, 2003
United States
Series D
2150
  [+7]

Acquired companies in Hamilton Apex's Portfolio

3 companies from Hamilton Apex's portfolio have been acquired. The most recent acquisition was Santarus in Nov 2013 by Salix Pharmaceuticals for $*****.
Here are Hamilton Apex's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Nov 07, 2013
May 22, 2003
Series D
3374
Aug 26, 2013
Aug 05, 2004
Series C
4939
Oct 19, 2005
May 29, 2003
Series A
2602

Team profile of Hamilton Apex

Hamilton Apex has a team of 1 member. Hamilton Apex's team does not sit on the board of any company as of now.

Co-investors of Hamilton Apex

Over the past 23 years, 20 investors have co-invested in Hamilton Apex's portfolio companies. This includes only funds.

  • Invested before Hamilton Apex: DFJ, Windward Ventures and 3 others have invested in rounds before Hamilton Apex. There is 1 company where DFJ has invested before Hamilton Apex and 1 company where Windward Ventures has invested before Hamilton Apex.
  • Top Co-investors of Hamilton Apex: 11 investors entered a company along with Hamilton Apex. These include investors like SR One (1 company).
  • Invested after Hamilton Apex: A total of 4 investors have invested in Hamilton Apex's portfolio after their investments. Top Investors include Investor (1 company), Hamilton BioVentures (1 company) and Cell Genesys (1 company).

FAQs about Hamilton Apex

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford